Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.81 CAD | +0.56% | -10.84% | -15.42% |
Sales 2024 * | 120M 87.15M | Sales 2025 * | 128M 93.14M | Capitalization | 82.76M 60.18M |
---|---|---|---|---|---|
Net income 2024 * | -6M -4.36M | Net income 2025 * | -13M -9.45M | EV / Sales 2024 * | 0.69 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.65 x |
P/E ratio 2024 * |
-11.4
x | P/E ratio 2025 * |
-7.52
x | Employees | 103 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.59% |
Latest transcript on Theratechnologies Inc.
1 day | -0.55% | ||
1 week | -10.45% | ||
Current month | -19.28% | ||
1 month | +6.51% | ||
3 months | -34.31% | ||
6 months | -23.08% | ||
Current year | -15.89% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Lévesque
CEO | Chief Executive Officer | 60 | 20-04-05 |
Philippe Dubuc
DFI | Director of Finance/CFO | 57 | 16-02-23 |
Chief Tech/Sci/R&D Officer | 61 | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Andrew Molson
BRD | Director/Board Member | 56 | 20-10-15 |
Frank Holler
BRD | Director/Board Member | 67 | 21-06-22 |
Director/Board Member | 80 | 06-02-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 1.81 | +0.56% | 4 800 |
24-04-17 | 1.8 | -0.55% | 4,375 |
24-04-16 | 1.81 | +0.56% | 7,309 |
24-04-15 | 1.8 | -4.76% | 38,323 |
24-04-12 | 1.89 | -6.90% | 42,140 |
Delayed Quote Toronto S.E., April 17, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.89% | 59.96M | |
-5.32% | 84.57B | |
+2.11% | 39.93B | |
-25.74% | 27.93B | |
+53.30% | 24.21B | |
-6.17% | 17.17B | |
-31.09% | 13.93B | |
-6.58% | 12.3B | |
-16.04% | 11.84B | |
-3.60% | 7.91B |
- Stock Market
- Equities
- TH Stock